Total Payments
$5,265
2024 Payments
$438.09
Companies
18
Transactions
176
Medicare Patients
481
Medicare Billing
$44,437
Payment Breakdown by Category
Food & Beverage$4,904 (93.2%)
Other$300.00 (5.7%)
Education$60.50 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,904 | 174 | 93.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $300.00 | 1 | 5.7% |
| Education | $60.50 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LivaNova USA, Inc. | $1,581 | 30 | $0 (2024) |
| UCB, Inc. | $1,507 | 67 | $0 (2024) |
| Cyberonics, Inc. | $444.02 | 8 | $0 (2017) |
| ABBVIE INC. | $420.67 | 8 | $0 (2024) |
| AQUESTIVE THERAPEUTICS, INC. | $272.51 | 16 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $213.09 | 16 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $202.62 | 12 | $0 (2022) |
| Greenwich Biosciences, Inc. | $162.00 | 5 | $0 (2021) |
| Tris Pharma Inc | $122.06 | 1 | $0 (2018) |
| SK Life Science, Inc. | $107.29 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $438.09 | 6 | ABBVIE INC. ($230.40) |
| 2023 | $834.60 | 15 | LivaNova USA, Inc. ($355.01) |
| 2022 | $140.33 | 9 | UCB, Inc. ($55.75) |
| 2021 | $260.54 | 20 | UCB, Inc. ($192.15) |
| 2020 | $471.71 | 27 | UCB, Inc. ($226.25) |
| 2019 | $1,101 | 46 | UCB, Inc. ($329.99) |
| 2018 | $883.08 | 19 | LivaNova USA, Inc. ($634.91) |
| 2017 | $1,136 | 34 | Cyberonics, Inc. ($444.02) |
All Payment Transactions
176 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $9.17 | General |
| Category: Neurology | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $120.65 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $109.43 | General |
| Category: Neurology | ||||||
| 03/28/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $73.04 | General |
| Category: Neurology | ||||||
| 02/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $109.75 | General |
| Category: NEUROSCIENCE | ||||||
| 01/09/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Neurology | ||||||
| 12/12/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $4.79 | General |
| Category: Neurology | ||||||
| 10/23/2023 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $119.86 | General |
| Category: Neurology | ||||||
| 10/11/2023 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $30.33 | General |
| Category: Neurology | ||||||
| 10/03/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $38.81 | General |
| Category: Neurology | ||||||
| 08/22/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2023 | LivaNova USA, Inc. | VNS Therapy (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/01/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $49.38 | General |
| Category: Neurology | ||||||
| 06/01/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $30.20 | General |
| Category: Neurology | ||||||
| 03/08/2023 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $55.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/07/2023 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Neurology | ||||||
| 02/01/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Neurology | ||||||
| 01/17/2023 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $10.45 | General |
| Category: Neurology | ||||||
| 11/30/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2022 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Neurology | ||||||
| 07/14/2022 | LivaNova USA, Inc. | VNS Therapy SenTiva Model 1000 Generator (Device) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 100 | 142 | $33,135 | $7,142 |
| 2022 | 4 | 115 | 144 | $31,000 | $12,794 |
| 2021 | 4 | 106 | 126 | $22,385 | $10,386 |
| 2020 | 6 | 160 | 191 | $41,080 | $14,114 |
Total Patients
481
Total Services
603
Medicare Billing
$44,437
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 45 | 55 | $10,725 | $5,134 | 47.9% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 40 | 72 | $20,160 | $1,880 | 9.3% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2023 | 15 | 15 | $2,250 | $128.52 | 5.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 44 | 50 | $9,750 | $5,939 | 60.9% |
| 99337 | Established patient custodial care facility, group care, or assisted living visit, typically 1 hour | Office | 2022 | 38 | 55 | $15,400 | $5,207 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 19 | $2,850 | $1,382 | 48.5% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2022 | 17 | 20 | $3,000 | $266.16 | 8.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 30 | 37 | $7,215 | $4,476 | 62.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 45 | $6,750 | $3,679 | 54.5% |
| 99337 | Established patient assisted living visit, typically 60 minutes | Office | 2021 | 14 | 14 | $3,920 | $1,804 | 46.0% |
| 95970 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device | Office | 2021 | 24 | 30 | $4,500 | $427.11 | 9.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 73 | 94 | $14,100 | $6,097 | 43.2% |
| 95957 | Digital analysis of electrical brain wave activity (eeg) | Office | 2020 | 14 | 14 | $6,860 | $2,578 | 37.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 21 | 24 | $4,680 | $2,103 | 44.9% |
| 95812 | Measurement of brain wave (eeg) activity, 41-60 minutes | Office | 2020 | 12 | 12 | $5,400 | $1,741 | 32.2% |
| 99337 | Established patient assisted living visit, typically 60 minutes | Office | 2020 | 21 | 23 | $6,440 | $1,337 | 20.8% |
| 95970 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device | Office | 2020 | 19 | 24 | $3,600 | $259.18 | 7.2% |
About Dr. Joan Dean, MD
Dr. Joan Dean, MD is a Neurology healthcare provider based in Winston Salem, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902832850.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joan Dean, MD has received a total of $5,265 in payments from pharmaceutical and medical device companies, with $438.09 received in 2024. These payments were reported across 176 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($4,904).
As a Medicare-enrolled provider, Dean has provided services to 481 Medicare beneficiaries, totaling 603 services with total Medicare billing of $44,437. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Winston Salem, NC
- Active Since 06/23/2006
- Last Updated 10/31/2013
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1902832850
Products in Payments
- VNS Therapy (Device) $1,846
- Briviact (Drug) $1,091
- QULIPTA (Drug) $382.27
- SYMPAZAN (Drug) $272.51
- OXTELLAR XR (Drug) $213.09
- APTIOM (Drug) $202.62
- Epidiolex (Drug) $162.00
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $128.05
- Dyanavel XR (Drug) $122.06
- Fintepla (Drug) $119.86
- Vimpat (Drug) $114.85
- Nayzilam (Drug) $107.88
- Cenobamate (Drug) $60.50
- ACTIVA (Device) $58.27
- VNS Therapy SenTiva Model 1000 Generator (Device) $39.13
- UBRELVY (Drug) $38.40
- Banzel (Drug) $23.75
- MIGRANAL (Drug) $17.89
- Horizant (Drug) $13.69
- VALTOCO (Drug) $13.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Winston Salem
Dr. David Hosford, Md, Phd, MD, PHD
Neurology — Payments: $169,152
Neurology $169,152
Mustafa Siddiqui, Md, MD
Neurology — Payments: $140,528
Neurology $140,528
Dr. Mitchell Isaac, Md, MD
Neurology — Payments: $102,670
Neurology $102,670
Indrani Acosta, M.d, M.D
Neurology — Payments: $54,391
Neurology $54,391
Mrs. Rachana Gandhi Mehta, M.d, M.D
Neurology — Payments: $53,251
Neurology $53,251
Aarti Sarwal, Md, MD
Neurology — Payments: $47,980
Neurology $47,980